Daily as of 3 Nov 16:00 ET
- Price
- between the two $8.29 vs 50 $8.72 / 200 $7.94
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 23 Jan 2026 · projected 11 bars out
IBRX | ImmunityBioNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$8.29
+$0.34 (+4.28%)
ImmunityBio (IBRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Jan 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $8.29 vs 50 $6.95 / 200 $4.39
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 27 Apr 2026 · projected 23 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $8.29 vs 50 $9.19 / 200 $8.23
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 3 Sep 2026 · projected 25 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 3 Sep 2026 | 🟨Golden | 4-hour | 25 bars out | — |
| 7 Aug 2026 | 💀Death | 4-hour | 27 bars out | 5 bar cross test |
| 17 Jul 2026 | 🟨Golden | 4-hour | 26 bars out | 3 bar cross test |
| 12 Jun 2026 | 💀Death | 4-hour | 16 bars out | Not tested |
| week of 27 Apr 2026 | 🟨Golden moderate | weekly | 23 bars out | Not tested |
About IBRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$77.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid